William S Redfern (Will S Redfern)

Years Active: 2017-2021
Publications (10 Years): 3

AstraZeneca plc

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AstraZeneca plc Oct 10 1998

United Kingdom

Principal Scientist :: Drug Safety & Metabolism

Publications

Matthew J Winter, Joseph Pinion, Anna Tochwin, Aya Takesono, Jonathan S Ball, Piotr Grabowski, Jeremy Metz, Maciej Trznadel, Karen Tse, William S Redfern, Malcolm J Hetheridge, Marc Goodfellow, Andrew D Randall, Charles R Tyler
Functional brain imaging in larval zebrafish for characterising the effects of seizurogenic compounds acting via a range of pharmacological mechanisms. British journal of pharmacology 178 (13) (2021)
Annette E Allen, Elizabeth A Martin, Katherine Greenwood, Claire Grant, Peter Vince, Robert J Lucas, William S Redfern
Effects of a monocarboxylate transport 1 inhibitor, AZD3965, on retinal and visual function in the rat. British journal of pharmacology 177 (20) (2020)
William S Redfern, Karen Tse, Claire Grant, Amy Keerie, David J Simpson, John C Pedersen, Victoria Rimmer, Lauren Leslie, Stephanie K Klein, Natasha A Karp, Rowland Sillito, Agis Chartsias, Tim Lukins, James Heward, Catherine Vickers, Kathryn Chapman, J Douglas Armstrong
Automated recording of home cage activity and temperature of individual rats housed in social groups: The Rodent Big Brother project. PloS one 12 (9) (2017)

William S Redfern.css-eqlu8i{font-size:small;padding-left:4px;} (Will S Redfern)